Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The cap-dependent translation apparatus integrates and amplifies cancer pathways.

Polunovsky VA, Bitterman PB.

RNA Biol. 2006 Jan-Mar;3(1):10-7. Epub 2006 Mar 15. Review.

PMID:
17114939
2.

Cap-dependent translation and control of the cell cycle.

Cormier P, Pyronnet S, Salaün P, Mulner-Lorillon O, Sonenberg N.

Prog Cell Cycle Res. 2003;5:469-75. Review.

PMID:
14593742
3.

Regulation of cap-dependent translation by eIF4E inhibitory proteins.

Richter JD, Sonenberg N.

Nature. 2005 Feb 3;433(7025):477-80. Review.

PMID:
15690031
4.

Translational control of eukaryotic gene expression.

Van Der Kelen K, Beyaert R, Inzé D, De Veylder L.

Crit Rev Biochem Mol Biol. 2009 Jul-Aug;44(4):143-68. doi: 10.1080/10409230902882090. Review.

PMID:
19604130
5.

Contrasting mechanisms of regulating translation of specific Drosophila germline mRNAs at the level of 5'-cap structure binding.

Lasko P, Cho P, Poulin F, Sonenberg N.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1544-6. Review.

PMID:
16246166
6.

eIF4E activity is regulated at multiple levels.

Raught B, Gingras AC.

Int J Biochem Cell Biol. 1999 Jan;31(1):43-57. Review.

PMID:
10216943
7.

mRNA stability and cancer: an emerging link?

Benjamin D, Moroni C.

Expert Opin Biol Ther. 2007 Oct;7(10):1515-29. Review.

PMID:
17916044
8.

eIF4E expression in tumors: its possible role in progression of malignancies.

De Benedetti A, Harris AL.

Int J Biochem Cell Biol. 1999 Jan;31(1):59-72. Review.

PMID:
10216944
9.
10.

The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.

Mita MM, Mita A, Rowinsky EK.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S169-77. Review.

PMID:
14508096
11.

Coordinate regulation of translation by the PI 3-kinase and mTOR pathways.

Martin KA, Blenis J.

Adv Cancer Res. 2002;86:1-39. Review.

PMID:
12374276
12.

Translation initiation: a critical signalling node in cancer.

Robert F, Pelletier J.

Expert Opin Ther Targets. 2009 Nov;13(11):1279-93. doi: 10.1517/14728220903241625. Review.

PMID:
19705976
13.

The role of translation in neoplastic transformation from a pathologist's point of view.

Rosenwald IB.

Oncogene. 2004 Apr 19;23(18):3230-47. Review.

PMID:
15094773
14.

The mRNA 5' cap-binding protein eIF4E and control of cell growth.

Sonenberg N, Gingras AC.

Curr Opin Cell Biol. 1998 Apr;10(2):268-75. Review.

PMID:
9561852
15.

Translational control: a target for cancer therapy.

Thumma SC, Kratzke RA.

Cancer Lett. 2007 Dec 8;258(1):1-8. Epub 2007 Oct 17. Review.

PMID:
17923280
16.

The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.

von der Haar T, Gross JD, Wagner G, McCarthy JE.

Nat Struct Mol Biol. 2004 Jun;11(6):503-11. Review.

PMID:
15164008
17.

Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies.

Bilanges B, Stokoe D.

Oncogene. 2007 Sep 6;26(41):5973-90. Epub 2007 Apr 2. Review.

PMID:
17404576
18.

mTOR, translation initiation and cancer.

Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N.

Oncogene. 2006 Oct 16;25(48):6416-22. Review.

PMID:
17041626
19.

STAT proteins as novel targets for cancer drug discovery.

Turkson J.

Expert Opin Ther Targets. 2004 Oct;8(5):409-22. Review.

PMID:
15469392
20.

Translational control: the cancer connection.

Clemens MJ, Bommer UA.

Int J Biochem Cell Biol. 1999 Jan;31(1):1-23. Review.

PMID:
10216939

Supplemental Content

Support Center